Cleo Commences U.S. Clinical Trials

Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to confirm the commencement of U.S. clinical trials

S&P 500 Tempest in a Teapot

As we have discussed many times, financial markets are fractal. Different timeframes produce similar price structures. This is a very valuable phenomena